ARMONK, New York, April 6, 2026, 10:34 EDT
IBM’s stock slipped about 0.7% to $246.43 in morning trading on Monday, after the company announced a fresh AI project win in India. Investors appeared to shrug off the news, keeping their attention fixed on the looming April 22 earnings release—widely seen as a key test of IBM’s AI growth story.
There’s a clear reason this is in focus now. IBM is pushing to convince investors that gains in AI and software can offset concerns tied to a lag in consulting and the waning mainframe surge. That February rout—shares plunged 13.2%, the steepest single-day slide since 2000—was triggered by Anthropic’s claim its Claude Code AI could update COBOL, the aging programming language still powering IBM mainframes across banks, insurers, and government agencies.
IBM’s own investor site pegs April 22 as the tentative date for Q1 results. Shares remain a long way from the $324.90 52-week high. On March 31, IBM gained 2.17%—better, but still trailing the S&P 500’s 2.91% and falling short of Microsoft and Alphabet, both of which logged bigger moves, according to MarketWatch.
IBM added to its growth narrative on Monday with news that Tata Play Fiber will tap IBM’s watsonx platform for an AI-ready data lakehouse—basically, a single hub to handle and analyze massive data sets. The plan pulls together 25 different data sources aiming to improve how Tata Play Fiber understands its customers. CEO Anand Sahai described watsonx as providing a “secure, scalable environment” for the initiative. IBM India News Room
Earlier this month, IBM announced on April 2 that it’s teaming up with Arm to build hardware tailored for AI and data-heavy tasks. Mohamed Awad, who heads Arm’s cloud AI division, called the partnership a move that will offer companies “greater flexibility” as they roll out and expand those platforms. IBM Newsroom
IBM’s recent performance has been strong. Back in January, the company topped Wall Street’s forecasts, posting fourth-quarter revenue of $19.69 billion and adjusted earnings at $4.52 per share. Software revenue jumped 14%, infrastructure up 21%. Chief Executive Arvind Krishna pointed to entering 2026 “with momentum,” projecting revenue growth above 5% in constant currency this year. Reuters
The debate isn’t over on the Street. Boerse Global noted Monday that 24 out of 33 recent analyst calls still recommend buying IBM—just one flagged a sell—while Erste Group hasn’t budged from its hold stance. Hans Engel at Erste pointed to the “increase in non-current liabilities” as a concern, also highlighting sluggish growth in consulting and softer momentum around the core mainframe business. Ad Hoc News
Some warn the market might be pushing the bearish view too far. Back in February, Jefferies’ Brent Thill pointed out that IBM had started tapping generative AI to convert COBOL into Java, adding that the company’s efforts to revive its software unit hinged more on AI, automation, and data—not just the mainframe story.
There’s a risk IBM’s upcoming results could reveal that AI-driven demand isn’t filtering through as consistently as hoped. Back in January, Reuters pointed out that Red Hat’s growth cooled to 10% in the fourth quarter. CFO Jim Kavanaugh projected roughly $600 million in dilution by 2026 tied to IBM’s Confluent deal. Boerse Global flagged another question for investors: will IBM’s recent FedRAMP approvals translate into actual federal revenue?
IBM announced April 1 that 11 of its AI and automation offerings—among them some from watsonx—had secured FedRAMP authorization, clearing a key U.S. government hurdle for cloud security, thanks to its tie-up with Amazon Web Services. Vanessa Hunt, who runs IBM’s federal tech business stateside, called the approval a “major milestone.” Investors will tune in April 22 for signs that wins like this, along with deals such as Tata Play Fiber, are feeding more consistent growth. IBM Newsroom
